Government of Oman approved COVAXIN for travel to Oman without quarantine

Posted On 2021-10-27

The government of the Sultanate of Oman has added COVAXIN to the approved list of COVID-19 vaccines for travel to Oman with the list of other vaccines including AstraZeneca/Covishield. The Civil Aviation Authority issued a notification on 27 October regarding this.

All passengers from India who have received two doses of COVAXIN at least 14 days before the estimated arrival date will now be able to travel to Oman without the requirement of quarantine. All other COVID-19 related requirements/conditions, such as the pre-arrival RT-PCR test shall be applicable for such passengers.

This notification will significantly ease travel to Oman for Indian nationals who have taken COVAXIN. Passengers who have taken AstraZeneca/Covishield are already permitted to travel to Oman without quarantine.

© 2021 All rights are reserved. Made by ProgrammingFire